Physiologically, upregulation of the mevalonate pathway in tumor cells results in the accumulation of phosphoantigens, such as isopentenyl pyrophosphate, which induce conformational changes of BTN3A1 in these cells (23). This evidence concerns the gene BTN3A1 and neoplasm.